Tammenoms Bakker Juliet
Insider CIK 1431159 · CORT 10% owner · RXST Director · MTEM 10% owner · COLL 10% owner · SRRA 10% owner · RPID 10% owner · VERO Director, 10% owner · ESPR 10% owner · KALA 10% owner · TCDA 10% owner · AXNX Director, 10% owner · AIMT 10% owner · APTX 10% owner · INZY 10% owner · EAR Director, 10% owner · ETNB 10% owner · TALS 10% owner · VERA 10% owner · CBLL Director · LXEO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RXST RxSight, Inc. | A Award | 2026-06-17 | 2026-06-18 | 37,037 | — | $0 | 85,183 | SEC↗ |
| CBLL Ceribell, Inc. | A Award | 2026-06-02 | 2026-06-04 | 7,838 | — | $0 | 23,284 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | S Sale | 2026-02-04 | 2026-02-06 | 49,000 | $3.88 | $190.1K | 0 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | S Sale | 2026-02-03 | 2026-02-03 | 27,500 | $4.24 | $116.6K | 49,000 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | S Sale | 2026-02-02 | 2026-02-03 | 27,500 | $4.25 | $116.9K | 76,500 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | S Sale | 2026-01-30 | 2026-02-03 | 46,000 | $4.54 | $208.8K | 104,000 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | X Exercise deriv | 2026-01-23 | 2026-02-03 | 500,000 | — | $0 | 0 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | X Exercise deriv | 2026-01-23 | 2026-02-03 | 129,032 | — | $0 | 0 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | S Sale | 2026-01-23 | 2026-02-03 | 7,739 | $4.06 | $31.4K | 4,029,245 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | X Exercise | 2026-01-23 | 2026-02-03 | 629,032 | $0.05 | $31.5K | 4,036,984 | SEC↗ |
| CBLL Ceribell, Inc. | A Award | 2025-06-10 | 2025-06-17 | 8,828 | — | $0 | 15,446 | SEC↗ |
| RXST RxSight, Inc. | A Award | 2025-06-03 | 2025-06-04 | 10,752 | — | $0 | 48,146 | SEC↗ |
| CBLL Ceribell, Inc. | C Conversion deriv | 2024-10-15 | 2024-10-16 | 2,140,600 | — | $0 | 0 | SEC↗ |
| CBLL Ceribell, Inc. | P Buy | 2024-10-15 | 2024-10-16 | 237,234 | $17.00 | $4.03M | 2,475,110 | SEC↗ |
| CBLL Ceribell, Inc. | C Conversion | 2024-10-15 | 2024-10-16 | 2,140,600 | — | $0 | 2,237,876 | SEC↗ |
| CBLL Ceribell, Inc. | A Award | 2024-10-11 | 2024-10-16 | 6,618 | — | $0 | 6,618 | SEC↗ |
| RXST RxSight, Inc. | A Award | 2024-06-06 | 2024-06-10 | 2,554 | — | $0 | 37,394 | SEC↗ |
| RXST RxSight, Inc. | P Buy | 2024-05-17 | 2024-05-21 | 5,000 | $61.09 | $305.4K | 34,840 | SEC↗ |
| RXST RxSight, Inc. | P Buy | 2024-02-14 | 2024-02-15 | 4,000 | $51.29 | $205.2K | 29,840 | SEC↗ |
| RXST RxSight, Inc. | P Buy | 2024-02-12 | 2024-02-15 | 4,000 | $50.38 | $201.5K | 25,840 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-11-30 | 2023-11-30 | 693 | — | $0 | 1,548 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-11-30 | 2023-11-30 | 445,400 | — | $0 | 0 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-11-30 | 2023-11-30 | 1,617 | — | $0 | 21,840 | SEC↗ |
| RXST RxSight, Inc. | S Sale | 2023-11-29 | 2023-11-30 | 349,245 | $29.77 | $10.40M | 0 | SEC↗ |
| RXST RxSight, Inc. | S Sale | 2023-11-28 | 2023-11-30 | 145,068 | $29.62 | $4.30M | 349,245 | SEC↗ |
| RXST RxSight, Inc. | S Sale | 2023-11-15 | 2023-11-16 | 400,000 | $27.20 | $10.88M | 494,313 | SEC↗ |
| RXST RxSight, Inc. | S Sale | 2023-11-14 | 2023-11-16 | 100,000 | $27.13 | $2.71M | 894,313 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | C Conversion deriv | 2023-11-07 | 2023-11-09 | 2,906,148 | — | $0 | 0 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | C Conversion deriv | 2023-11-07 | 2023-11-09 | 18,999,999 | — | $0 | 0 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | C Conversion | 2023-11-07 | 2023-11-09 | 1,793,429 | — | $0 | 1,793,429 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | C Conversion | 2023-11-07 | 2023-11-09 | 319,126 | — | $0 | 2,112,555 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | P Buy | 2023-11-07 | 2023-11-09 | 454,545 | $11.00 | $5.00M | 2,567,100 | SEC↗ |
| RXST RxSight, Inc. | S Sale | 2023-09-11 | 2023-09-11 | 2,950 | $30.01 | $88.5K | 20,223 | SEC↗ |
| RXST RxSight, Inc. | S Sale | 2023-09-08 | 2023-09-11 | 10,033 | $30.25 | $303.5K | 23,173 | SEC↗ |
| RXST RxSight, Inc. | S Sale | 2023-09-07 | 2023-09-11 | 19,967 | $30.10 | $601.0K | 33,206 | SEC↗ |
| RXST RxSight, Inc. | S Sale | 2023-08-25 | 2023-08-28 | 16,208 | $29.25 | $474.1K | 53,173 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-08-24 | 2023-08-28 | 267,300 | — | $0 | 445,400 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-08-24 | 2023-08-28 | 970 | — | $0 | 69,381 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-08-24 | 2023-08-28 | 416 | — | $0 | 855 | SEC↗ |
| RXST RxSight, Inc. | S Sale | 2023-08-18 | 2023-08-18 | 14,651 | $29.07 | $425.9K | 68,411 | SEC↗ |
| RXST RxSight, Inc. | S Sale | 2023-08-17 | 2023-08-18 | 18,484 | $30.06 | $555.6K | 83,062 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-08-09 | 2023-08-11 | 497,150 | — | $0 | 994,313 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-08-09 | 2023-08-11 | 32,950 | — | $0 | 101,546 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-06-14 | 2023-06-16 | 267,300 | — | $0 | 712,700 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-06-14 | 2023-06-16 | 439 | — | $0 | 439 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-06-14 | 2023-06-16 | 1,022 | — | $0 | 68,596 | SEC↗ |
| RXST RxSight, Inc. | A Award | 2023-06-01 | 2023-06-05 | 5,731 | — | $0 | 67,574 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-05-26 | 2023-05-31 | 497,150 | — | $0 | 1,491,463 | SEC↗ |
| RXST RxSight, Inc. | J Other | 2023-05-26 | 2023-05-31 | 33,135 | — | $0 | 61,843 | SEC↗ |
| RXST RxSight, Inc. | P Buy | 2023-02-10 | 2023-02-13 | 480,000 | $12.50 | $6.00M | 980,000 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-02-06 | 2023-02-08 | 1,714,285 | $7.00 | $12.00M | 1,714,285 | SEC↗ |
| RXST RxSight, Inc. | A Award | 2022-06-02 | 2022-06-03 | 10,349 | — | $0 | 28,708 | SEC↗ |
| SRRA Sierra Oncology, Inc. | J Other | 2022-04-27 | 2022-04-29 | 1,964,771 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | J Other | 2022-04-27 | 2022-04-29 | 588 | — | $0 | 5,611 | SEC↗ |
| SRRA Sierra Oncology, Inc. | J Other | 2022-04-27 | 2022-04-29 | 840 | — | $0 | 8,015 | SEC↗ |
| SRRA Sierra Oncology, Inc. | J Other | 2022-04-27 | 2022-04-29 | 252 | — | $0 | 2,404 | SEC↗ |
| SRRA Sierra Oncology, Inc. | J Other | 2022-04-27 | 2022-04-29 | 175,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | J Other | 2022-04-27 | 2022-04-29 | 7,175 | — | $0 | 7,175 | SEC↗ |
| SRRA Sierra Oncology, Inc. | J Other | 2022-04-27 | 2022-04-29 | 5,023 | — | $0 | 5,023 | SEC↗ |
| SRRA Sierra Oncology, Inc. | J Other | 2022-04-27 | 2022-04-29 | 2,152 | — | $0 | 2,152 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2022-04-19 | 2022-04-21 | 1,355,000 | $3.69 | $5.00M | 4,174,379 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2022-02-10 | 2022-04-05 | 333,333 | $15.00 | $5.00M | 3,429,927 | SEC↗ |
| SRRA Sierra Oncology, Inc. | P Buy | 2022-02-02 | 2022-02-02 | 175,000 | $27.00 | $4.72M | 175,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-25 | 2022-01-27 | 1,477,125 | $13.20 | $19.50M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-25 | 2022-01-27 | 487,451 | $13.20 | $6.43M | 1,964,771 | SEC↗ |
| RXST RxSight, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 242,013 | — | $0 | 0 | SEC↗ |
| RXST RxSight, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 8,177 | — | $0 | 0 | SEC↗ |
| RXST RxSight, Inc. | F Tax w/h deriv | 2021-08-03 | 2021-08-05 | 28,125 | — | $0 | 8,177 | SEC↗ |
| RXST RxSight, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 1,613,423 | — | $0 | 0 | SEC↗ |
| RXST RxSight, Inc. | M Exercise deriv | 2021-08-03 | 2021-08-05 | 36,302 | — | $0 | 0 | SEC↗ |
| RXST RxSight, Inc. | M Exercise deriv | 2021-08-03 | 2021-08-05 | 36,302 | — | $0 | 36,302 | SEC↗ |
| RXST RxSight, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 500,000 | $16.00 | $8.00M | 500,000 | SEC↗ |
| RXST RxSight, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 12,500 | $16.00 | $200.0K | 18,359 | SEC↗ |
| RXST RxSight, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 1,863,613 | — | $0 | 1,863,613 | SEC↗ |
| RXST RxSight, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 125,000 | $16.00 | $2.00M | 1,988,613 | SEC↗ |
| RXST RxSight, Inc. | A Award | 2021-07-30 | 2021-08-02 | 5,859 | — | $0 | 5,859 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | C Conversion deriv | 2021-07-19 | 2021-07-20 | 2,291,665 | — | $0 | 0 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | C Conversion deriv | 2021-07-19 | 2021-07-20 | 500,000 | — | $0 | 500,000 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | C Conversion deriv | 2021-07-19 | 2021-07-20 | 2,500,000 | — | $0 | 0 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | C Conversion deriv | 2021-07-19 | 2021-07-20 | 645,160 | — | $0 | 0 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | C Conversion deriv | 2021-07-19 | 2021-07-20 | 5,654,529 | — | $0 | 0 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | C Conversion deriv | 2021-07-19 | 2021-07-20 | 8,774,007 | — | $0 | 0 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | C Conversion deriv | 2021-07-19 | 2021-07-20 | 129,032 | — | $0 | 129,032 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | C Conversion | 2021-07-19 | 2021-07-20 | 3,344,038 | — | $0 | 3,407,952 | SEC↗ |
| RPID RAPID MICRO BIOSYSTEMS, IN | P Buy | 2021-07-19 | 2021-07-20 | 150,000 | $20.00 | $3.00M | 150,000 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion deriv | 2021-05-18 | 2021-05-18 | 2,187,504 | — | $0 | 0 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2021-05-18 | 2021-05-18 | 909,090 | $11.00 | $10.00M | 3,096,594 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion | 2021-05-18 | 2021-05-18 | 2,187,504 | — | $0 | 2,187,504 | SEC↗ |
| EAR Eargo, Inc. | J Other | 2021-05-17 | 2021-05-19 | 3,508 | — | $0 | 7,016 | SEC↗ |
| EAR Eargo, Inc. | J Other | 2021-05-17 | 2021-05-19 | 1,504 | — | $0 | 3,008 | SEC↗ |
| EAR Eargo, Inc. | J Other | 2021-05-17 | 2021-05-19 | 1,000,000 | — | $0 | 1,918,691 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-11 | 1,271,027 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-11 | 1,308,410 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion deriv | 2021-05-11 | 2021-05-11 | 406,338 | — | $0 | 0 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | P Buy | 2021-05-11 | 2021-05-11 | 235,000 | $17.00 | $4.00M | 3,220,775 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | C Conversion | 2021-05-11 | 2021-05-11 | 2,985,775 | — | $0 | 2,985,775 | SEC↗ |
| EAR Eargo, Inc. | J Other | 2021-04-14 | 2021-04-15 | 3,508 | — | $0 | 3,508 | SEC↗ |
| EAR Eargo, Inc. | J Other | 2021-04-14 | 2021-04-15 | 1,000,000 | — | $0 | 2,918,691 | SEC↗ |
| EAR Eargo, Inc. | J Other | 2021-04-14 | 2021-04-15 | 1,504 | — | $0 | 1,504 | SEC↗ |
| ETNB 89bio, Inc. | J Other | 2020-11-16 | 2020-11-18 | 891 | — | $0 | 891 | SEC↗ |
| ETNB 89bio, Inc. | J Other | 2020-11-16 | 2020-11-18 | 850,000 | — | $0 | 1,750,877 | SEC↗ |
| ETNB 89bio, Inc. | J Other | 2020-11-16 | 2020-11-18 | 2,080 | — | $0 | 2,080 | SEC↗ |
| ETNB 89bio, Inc. | J Other | 2020-11-16 | 2020-11-18 | 2,973 | — | $0 | 2,973 | SEC↗ |
| EAR Eargo, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-22 | 3,685,358 | — | $0 | 0 | SEC↗ |
| EAR Eargo, Inc. | C Conversion | 2020-10-20 | 2020-10-22 | 3,685,358 | — | $0 | 3,685,358 | SEC↗ |
| EAR Eargo, Inc. | P Buy | 2020-10-20 | 2020-10-22 | 233,333 | $18.00 | $4.20M | 3,918,691 | SEC↗ |
| EAR Eargo, Inc. | A Award deriv | 2020-10-15 | 2020-10-19 | 6,666 | — | $0 | 6,666 | SEC↗ |
| AXNX Axonics Modulation Technol | S Sale | 2020-09-18 | 2020-09-22 | 9,167 | $42.67 | $391.2K | 3,500 | SEC↗ |
| MTEM Molecular Templates, Inc. | S Sale | 2020-08-28 | 2020-09-01 | 1,049 | $10.75 | $11.3K | 0 | SEC↗ |
| MTEM Molecular Templates, Inc. | S Sale | 2020-08-28 | 2020-09-01 | 2,447 | $10.75 | $26.3K | 0 | SEC↗ |
| AXNX Axonics Modulation Technol | A Award | 2020-08-24 | 2020-08-26 | 3,500 | — | $0 | 12,667 | SEC↗ |
| AXNX Axonics Modulation Technol | S Sale | 2020-08-14 | 2020-08-18 | 2,393 | $43.22 | $103.4K | 9,167 | SEC↗ |
| AXNX Axonics Modulation Technol | J Other | 2020-08-10 | 2020-08-12 | 1,026 | — | $0 | 1,026 | SEC↗ |
| AXNX Axonics Modulation Technol | J Other | 2020-08-10 | 2020-08-12 | 2,393 | — | $0 | 11,560 | SEC↗ |
| AXNX Axonics Modulation Technol | J Other | 2020-08-10 | 2020-08-12 | 978,000 | — | $0 | 1,955,333 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 1,398,600 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 15,000,000 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 187,154 | — | $0 | 2,194,379 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2020-07-28 | 2020-07-28 | 625,000 | $16.00 | $10.00M | 2,819,379 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 2,007,225 | — | $0 | 2,007,225 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2020-07-10 | 2020-07-14 | 109,090 | $27.50 | $3.00M | 2,600,877 | SEC↗ |
| MTEM Molecular Templates, Inc. | J Other | 2020-05-26 | 2020-05-28 | 1,000,000 | — | $0 | 3,199,035 | SEC↗ |
| MTEM Molecular Templates, Inc. | J Other | 2020-05-26 | 2020-05-28 | 3,495 | — | $0 | 3,495 | SEC↗ |
| MTEM Molecular Templates, Inc. | J Other | 2020-05-26 | 2020-05-28 | 2,447 | — | $0 | 2,447 | SEC↗ |
| MTEM Molecular Templates, Inc. | J Other | 2020-05-26 | 2020-05-28 | 1,049 | — | $0 | 1,049 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-01-31 | 19,500 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-01-31 | 1,477,320 | — | $0 | 1,477,320 | SEC↗ |
| MTEM Molecular Templates, Inc. | P Buy | 2019-11-25 | 2019-11-27 | 937,000 | $8.00 | $7.50M | 4,198,535 | SEC↗ |
| MTEM Molecular Templates, Inc. | P Buy | 2019-11-25 | 2019-12-05 | 937,500 | $8.00 | $7.50M | 4,199,035 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 11,916,667 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion | 2019-11-13 | 2019-11-13 | 1,916,787 | — | $0 | 2,491,787 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2019-11-11 | 2019-11-13 | 575,000 | $16.00 | $9.20M | 575,000 | SEC↗ |
| VERO Venus Concept Inc. | A Award deriv | 2019-11-07 | 2019-11-07 | 8,650 | — | $0 | 8,650 | SEC↗ |
| VERO Venus Concept Inc. | A Award deriv | 2019-11-07 | 2019-11-07 | 17,301 | — | $0 | 17,301 | SEC↗ |
| VERO Venus Concept Inc. | A Award | 2019-11-07 | 2019-11-07 | 3,476,584 | — | $0 | 3,476,584 | SEC↗ |
| VERO Venus Concept Inc. | A Award | 2019-11-07 | 2019-11-07 | 189,535 | — | $0 | 3,666,119 | SEC↗ |
| AXNX Axonics Modulation Technol | A Award deriv | 2019-08-22 | 2019-08-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AXNX Axonics Modulation Technol | A Award | 2019-08-22 | 2019-08-26 | 5,000 | — | $0 | 9,167 | SEC↗ |
| AXNX Axonics Modulation Technol | A Award deriv | 2019-06-27 | 2019-07-01 | 5,000 | — | $0 | 5,000 | SEC↗ |
| AXNX Axonics Modulation Technol | A Award deriv | 2019-06-27 | 2019-08-15 | 3,333 | — | $0 | 3,333 | SEC↗ |
| AXNX Axonics Modulation Technol | A Award | 2019-06-27 | 2019-07-01 | 1,667 | — | $0 | 4,167 | SEC↗ |
| AXNX Axonics Modulation Technol | A Award deriv | 2018-12-06 | 2018-12-10 | 5,000 | — | $0 | 5,000 | SEC↗ |
| AXNX Axonics Modulation Technol | A Award | 2018-12-06 | 2018-12-10 | 2,500 | — | $0 | 2,500 | SEC↗ |
| AXNX Axonics Modulation Technol | C Conversion deriv | 2018-11-02 | 2018-11-02 | 2,000,000 | — | $0 | 0 | SEC↗ |
| AXNX Axonics Modulation Technol | C Conversion | 2018-11-02 | 2018-11-02 | 2,400,000 | — | $0 | 2,400,000 | SEC↗ |
| AXNX Axonics Modulation Technol | P Buy | 2018-11-02 | 2018-11-02 | 533,333 | $15.00 | $8.00M | 2,933,333 | SEC↗ |
| MTEM Molecular Templates, Inc. | P Buy | 2018-09-21 | 2018-09-25 | 365,000 | $5.50 | $2.01M | 3,261,535 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 9,677,419 | — | $0 | 0 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 1,817,447 | — | $0 | 0 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 2,431,511 | — | $0 | 2,431,511 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 456,644 | — | $0 | 2,888,155 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2018-07-02 | 2018-07-02 | 131,579 | $19.00 | $2.50M | 3,019,734 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 21,946,301 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 33,022,786 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion deriv | 2018-06-25 | 2018-06-26 | 28,895,188 | — | $0 | 0 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 795,553 | — | $0 | 3,040,079 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 1,047,450 | — | $0 | 1,047,450 | SEC↗ |
| APTX Aptinyx Inc. | P Buy | 2018-06-25 | 2018-06-26 | 150,000 | $16.00 | $2.40M | 3,190,079 | SEC↗ |
| APTX Aptinyx Inc. | C Conversion | 2018-06-25 | 2018-06-26 | 1,197,076 | — | $0 | 2,244,526 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2018-02-22 | 2018-02-26 | 9,375 | $32.00 | $300.0K | 16,651 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | S Sale | 2017-12-08 | 2017-12-12 | 19,650 | $17.34 | $340.7K | 45,620 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | S Sale | 2017-12-08 | 2017-12-12 | 980,350 | $17.34 | $17.00M | 2,276,222 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | C Conversion deriv | 2017-07-25 | 2017-07-27 | 10,707,985 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | C Conversion | 2017-07-25 | 2017-07-27 | 2,055,946 | — | $0 | 2,055,946 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | P Buy | 2017-07-25 | 2017-07-27 | 215,000 | $15.00 | $3.23M | 2,270,946 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | G Gift | 2016-12-15 | 2016-12-19 | 70,671 | — | $0 | 133,539 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | J Other | 2016-12-12 | 2016-12-14 | 204,210 | — | $0 | 204,210 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | J Other | 2016-11-29 | 2016-12-01 | 7,276 | — | $0 | 7,276 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | J Other | 2016-11-29 | 2016-12-01 | 1,500,000 | — | $0 | 6,013,134 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | J Other | 2016-11-28 | 2016-11-30 | 2,941,050 | — | $0 | 10,834,849 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | J Other | 2016-11-28 | 2016-11-30 | 58,950 | — | $0 | 121,153 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2016-11-25 | 2016-11-25 | 14,451 | $9.39 | $135.7K | 13,775,899 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2016-11-25 | 2016-11-25 | 290 | $9.39 | $2.7K | 180,103 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2016-11-23 | 2016-11-25 | 12,352 | $9.30 | $114.9K | 13,790,350 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2016-11-23 | 2016-11-25 | 248 | $9.30 | $2.3K | 180,393 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2016-11-22 | 2016-11-25 | 189 | $9.33 | $1.8K | 180,641 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2016-11-22 | 2016-11-25 | 9,411 | $9.33 | $87.8K | 13,802,702 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2016-11-21 | 2016-11-21 | 2,327 | $9.39 | $21.9K | 180,830 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2016-11-21 | 2016-11-21 | 116,058 | $9.39 | $1.09M | 13,812,113 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2016-11-18 | 2016-11-21 | 98,586 | $9.47 | $933.6K | 13,928,171 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2016-11-18 | 2016-11-21 | 1,976 | $9.47 | $18.7K | 183,157 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2016-11-17 | 2016-11-21 | 6,389 | $9.64 | $61.6K | 185,133 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2016-11-17 | 2016-11-21 | 318,764 | $9.64 | $3.07M | 14,026,757 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2016-11-16 | 2016-11-17 | 17,052 | $9.51 | $162.2K | 14,345,521 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2016-11-16 | 2016-11-17 | 342 | $9.51 | $3.3K | 191,522 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2016-11-15 | 2016-11-17 | 3,094 | $9.55 | $29.5K | 191,864 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2016-11-15 | 2016-11-17 | 154,359 | $9.55 | $1.47M | 14,362,573 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2016-03-29 | 2016-03-31 | 45,440 | $14.15 | $643.0K | 7,513,134 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2016-03-29 | 2016-03-31 | 33,064 | $13.50 | $446.4K | 7,467,694 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | C Conversion deriv | 2015-08-11 | 2015-08-11 | 3,873,530 | — | $0 | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | C Conversion deriv | 2015-08-11 | 2015-08-11 | 3,248,600 | — | $0 | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | C Conversion | 2015-08-11 | 2015-08-11 | 3,873,530 | — | $0 | 3,873,530 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2015-08-11 | 2015-08-11 | 312,500 | $16.00 | $5.00M | 7,434,630 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | C Conversion | 2015-08-11 | 2015-08-11 | 3,248,600 | — | $0 | 7,122,130 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-14 | 63,356 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-14 | 3,160,905 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-14 | 101,128 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-14 | 12,837,935 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-14 | 5,045,381 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-14 | 257,303 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | P Buy | 2015-05-12 | 2015-05-14 | 3,930 | $12.00 | $47.2K | 65,270 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-14 | 61,340 | — | $0 | 61,340 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | P Buy | 2015-05-12 | 2015-05-14 | 196,070 | $12.00 | $2.35M | 3,256,572 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-14 | 3,060,502 | — | $0 | 3,060,502 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | X Exercise deriv | 2015-03-30 | 2015-04-01 | 16,833 | — | $0 | 0 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | X Exercise deriv | 2015-03-30 | 2015-04-01 | 839,811 | — | $0 | 0 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | X Exercise | 2015-03-30 | 2015-04-01 | 16,833 | $4.05 | $68.2K | 194,958 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | X Exercise | 2015-03-30 | 2015-04-01 | 839,811 | $4.05 | $3.40M | 14,516,932 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | X Exercise deriv | 2015-03-24 | 2015-03-24 | 1,130,709 | — | $0 | 0 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | X Exercise | 2015-03-24 | 2015-03-24 | 1,130,709 | $2.77 | $3.13M | 14,231,469 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2015-03-24 | 2015-03-24 | 554,348 | $5.65 | $3.13M | 13,677,121 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | X Exercise deriv | 2015-03-20 | 2015-03-24 | 486,443 | — | $0 | 0 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | X Exercise deriv | 2015-03-20 | 2015-03-24 | 634,516 | — | $0 | 1,130,709 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | X Exercise deriv | 2015-03-20 | 2015-03-24 | 9,750 | — | $0 | 0 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | X Exercise | 2015-03-20 | 2015-03-24 | 9,750 | $2.77 | $27.0K | 182,742 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2015-03-20 | 2015-03-24 | 230,333 | $5.85 | $1.35M | 13,100,760 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2015-03-20 | 2015-03-24 | 300,447 | $5.85 | $1.76M | 12,844,650 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | X Exercise | 2015-03-20 | 2015-03-24 | 634,516 | $2.77 | $1.76M | 13,145,097 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2015-03-20 | 2015-03-24 | 4,617 | $5.85 | $27.0K | 178,125 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | X Exercise | 2015-03-20 | 2015-03-24 | 486,443 | $2.77 | $1.35M | 13,331,093 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2014-11-18 | 2014-11-19 | 4,592 | $31.56 | $144.9K | 1,406,622 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2014-11-18 | 2014-11-19 | 412 | $32.14 | $13.2K | 1,406,210 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2014-11-18 | 2014-11-19 | 92 | $31.57 | $2.9K | 28,194 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2014-11-18 | 2014-11-19 | 8 | $32.13 | $257 | 28,186 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2014-11-17 | 2014-11-19 | 4,021 | $32.01 | $128.7K | 33,736 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2014-11-17 | 2014-11-19 | 2,728 | $32.93 | $89.8K | 31,008 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2014-11-17 | 2014-11-19 | 2,722 | $33.79 | $92.0K | 28,286 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2014-11-17 | 2014-11-19 | 135,816 | $33.79 | $4.59M | 1,411,214 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2014-11-17 | 2014-11-19 | 136,148 | $32.93 | $4.48M | 1,547,030 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2014-11-17 | 2014-11-19 | 200,591 | $32.01 | $6.42M | 1,683,178 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2014-10-09 | 2014-10-14 | 924 | $30.00 | $27.7K | 1,883,769 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2014-10-09 | 2014-10-14 | 19 | $30.00 | $570 | 37,757 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2014-10-07 | 2014-10-09 | 235 | $30.04 | $7.1K | 37,776 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2014-10-07 | 2014-10-09 | 11,692 | $30.04 | $351.2K | 1,884,693 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2014-05-02 | 2014-05-05 | 84,744 | $4.07 | $344.9K | 12,510,581 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2014-05-02 | 2014-05-05 | 1,699 | $4.07 | $6.9K | 172,992 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2014-05-01 | 2014-05-05 | 3,214 | $4.12 | $13.2K | 174,691 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2014-05-01 | 2014-05-05 | 160,343 | $4.12 | $660.6K | 12,595,325 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2014-04-01 | 2014-04-03 | 4,912 | $4.28 | $21.0K | 177,905 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2014-04-01 | 2014-04-03 | 245,088 | $4.28 | $1.05M | 12,755,668 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2014-03-07 | 2014-03-07 | 10,225 | $4.00 | $40.9K | 13,000,756 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2014-03-07 | 2014-03-07 | 205 | $4.00 | $820 | 182,817 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2014-03-06 | 2014-03-07 | 164,800 | $4.00 | $659.2K | 13,010,981 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2014-03-06 | 2014-03-07 | 3,303 | $4.00 | $13.2K | 183,022 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2014-03-05 | 2014-03-07 | 1,404 | $4.01 | $5.6K | 186,325 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | S Sale | 2014-03-05 | 2014-03-07 | 70,063 | $4.01 | $281.0K | 13,175,781 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion deriv | 2013-07-01 | 2013-07-01 | 1,683,967 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion deriv | 2013-07-01 | 2013-07-01 | 33,753 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion | 2013-07-01 | 2013-07-01 | 1,683,967 | — | $0 | 1,683,967 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2013-07-01 | 2013-07-01 | 212,418 | $14.00 | $2.97M | 1,896,385 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2013-07-01 | 2013-07-01 | 4,258 | $14.00 | $59.6K | 38,011 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion | 2013-07-01 | 2013-07-01 | 33,753 | — | $0 | 33,753 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | P Buy deriv | 2012-03-29 | 2012-04-02 | 856,644 | $0.13 | $111.4K | 856,644 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | X Exercise deriv | 2012-03-29 | 2012-04-02 | 856,644 | $0.13 | $111.4K | 0 | SEC↗ |
| CORT CORCEPT THERAPEUTICS INC | X Exercise | 2012-03-29 | 2012-04-02 | 856,644 | $2.96 | $2.54M | 13,433,573 | SEC↗ |